Dapagliflozin Improved Cardiac Function and Structure in Diabetic Patients with Preserved Ejection Fraction: Results of a Single Centre, Observational Prospective Study

Sodium-glucose cotransporter inhibitors (SGLT2i) have demonstrated a reduction in cardiovascular events in diabetes and heart failure (HF). The mechanisms underlying this benefit are not well known and data are contradictory. The purpose of this study is to analyse the effect of dapagliflozin on car...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortés, Marcelino, Lorenzo, Oscar, Lumpuy-Castillo, Jairo, Martínez-Albaladejo, Sacramento, Taibo-Urquía, Mikel, Pello, Ana María, Bollas, Antonio José, Orejas, Miguel, Navas, Miguel Ángel, Macia, Ester, Martínez, María Esther, Rueda, Andrea, Tuñón, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607224/
https://www.ncbi.nlm.nih.gov/pubmed/37892836
http://dx.doi.org/10.3390/jcm12206698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607224/
https://www.ncbi.nlm.nih.gov/pubmed/37892836
http://dx.doi.org/10.3390/jcm12206698

Ejemplares similares